Skip to main content

Evolus, Inc.

EOLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001570562

In the last 90 days, Evolus, Inc. insiders filed 0 open-market purchases and 1 sale; 158 institutions reported holding it in 13F filings for Q2 2026, worth $335.1M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Evolus, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of EOLS: Q1 2025 compared with Q2 2025
MeasureQ1 2025Of which not filed for Q2 2025Q2 2025Change
Holders1791172−6
Shares54.3M1158.5M+4.24M (+7.8%)
Value$652.9M$132$538.8M−$114.1M (−17.5%)

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Evolus, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to EOLS in Q2 2025
InstitutionSharesValue% of portfolio
Frazier Life Sciences Management, L.P.2,435,550$22.4M0.90%
Eversept Partners, LP1,170,311$10.8M1.09%
Pinnacle Associates Ltd685,960$6.32M0.09%
First Light Asset Management, LLC520,631$4.80M0.62%
Woodline Partners LP204,562$1.88M0.01%
National Philanthropic Trust200,000$1.84M0.02%
Marshall Wace, LLP67,846$624.9K0.00%
HighVista Strategies LLC58,042$534.6K0.20%
Occudo Quantitative Strategies LP47,502$437.5K0.05%
Campbell & CO Investment Adviser LLC47,157$434.3K0.03%
Engineers Gate Manager LP34,999$322.3K0.00%
Virtu Financial LLC30,521$281.0K0.01%
Pathstone Holdings, LLC28,050$258.3K0.00%
Bender Robert & Associates25,070$230.9K0.05%
Quantinno Capital Management LP16,342$150.5K0.00%
Diametric Capital, LP16,052$147.8K0.08%
Caxton Associates LLP16,029$147.6K0.00%
DRW Securities, LLC13,297$122.5K0.01%
Atom Investors LP12,877$118.6K0.01%
Versor Investments LP11,049$101.8K0.02%
Profund Advisors LLC10,833$99.8K0.00%
Manchester Capital Management LLC2,870$26.4K0.00%
Global Retirement Partners, LLC2,650$24.4K0.00%
Key Financial Inc1,500$13.8K0.00%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.499$5.00K0.00%
Newbridge Financial Services Group, Inc.200$1.84K0.00%
Allworth Financial LP88$8110.00%
Assetmark, Inc30$2760.00%

Sold out (34)

Institutions that held Evolus, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Not filed for Q2 2025 yet (1)

Institutions that held Evolus, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding EOLS in Q1 2025 that haven't filed for Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Lindbrook Capital, LLC11$132